Acknowledging the kind of traction gained by this market, Industry Data Analytics recently published a study report asserts the global Radioactive Stent Used for Cancer Treatments Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 5.7% during the review period (2022 to 2027).
Radioactive stents are small expandable tubes that are used in prevention of restenosis and coronary artery lesions, and in improving catheter-based revascularization. These stents are widely utilized in cancer treatment as they utilize high-energy gamma rays that destroy the cancer cells and prevent their proliferation.Now, Radioactive Stent are still mainly used in the Esophageal Cancer Therapy. While many scientists and doctors are expanding its application on other cancer therapy.
As per the article published in Cancer Connect 2020, doctors from Dana Farber Cancer Institute determined that during the COVID-19 pandemic, there was a 46% decrease in the diagnoses of the six most common cancer types - breast, colorectal, lung, pancreatic, gastric, and esophageal cancers. Also, the Centers for Disease Control and Prevention (CDC) and many medical professional organizations recommended that cancer screening and other health prevention services, along with elective surgeries, to be postponed unless the risks outweighed the benefits and to secure the hospital infrastructure for the treatment of COVID-19 patients. Thus, the COVID-19 pandemic has impacted the cancer therapy market. However, the situation is expected to gradually improve.
Top Key players in the Radioactive Stent Used for Cancer Treatments Market have been identified through secondary research, and their market shares have been determined through primary and secondary research. The global Radioactive Stent Used for Cancer Treatments Market is fragmented with a large number of small players operating worldwide. The companies referred in the market research report includes Micro-Tech, Changzhou Zhiye, Changzhou Garson,Sanofi, Merck & Co., Inc, Otsuka Pharmaceutical Co., Ltd, Mylan N.V., Amgen Inc, Novartis AG, Amneal Pharmaceuticals Inc, Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Pfizer Inc, Teikoku Pharma USA, Inc. and Jiangsu Hengrui Medicine Co., Ltd and others.
Industry News:
26-Apr-2021: Drugs Approved for Esophageal Cancer: cancer drugs approved by the Food and Drug Administration (FDA) for esophageal cancer, including gastroesophageal junction cancer. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in esophageal cancer
Radioactive Stent Used for Cancer Treatments Market is segmented based on the type, applications, companies and regions.
By Type, the Radioactive Stent Used for Cancer Treatments Market has been segmented into
The end user’s industry application on Radioactive Stent Used for Cancer Treatments Market is,
A rise in focus of vendors on the emerging markets, such as Asia-Pacific and LAMEA is expected to boost the market growth. Asia-Pacific is projected to witness significant growth in future, owing to increase in R&D investment and surge in cancer awareness. Europe is considered a second largest growing regional segment due to the presence of refined healthcare infrastructure and high diagnostic rate. Asia-Pacific leads the market due to the developing healthcare facilities, large number of generic manufacturer and rise in government initiatives and specialist communities.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 5.7% during the review period (2022 to 2027). |
By Type |
|
By Application |
|
By Companies | Micro-Tech, Changzhou Zhiye, Changzhou Garson,Sanofi, Merck & Co., Inc, Otsuka Pharmaceutical Co., Ltd, Mylan N.V., Amgen Inc, Novartis AG, Amneal Pharmaceuticals Inc, Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Pfizer Inc, Teikoku Pharma USA, Inc. and Jiangsu Hengrui Medicine Co., Ltd and others. |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 99 |
Customization Available | Yes, the report can be customized as per your needs |
What is the study period of this market?
The Radioactive Stent Used for Cancer Treatments Market is studied from 2017 - 2027.
What is the growth rate of Radioactive Stent Used for Cancer Treatments Market?
The Radioactive Stent Used for Cancer Treatments Market is growing at a CAGR of 5.7% over the next 5 years.
Who are the leading key players in Radioactive Stent Used for Cancer Treatments Market?
Micro-Tech, Changzhou Zhiye, Changzhou Garson,Sanofi, Merck & Co., Inc, Otsuka Pharmaceutical Co., Ltd, Mylan N.V., Amgen Inc, Novartis AG, Amneal Pharmaceuticals Inc, Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Pfizer Inc, Teikoku Pharma USA, Inc. and Jiangsu Hengrui Medicine Co., Ltd and others.
What regions regions does this Radioactive Stent Used for Cancer Treatments Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Radioactive Stent Used for Cancer Treatments Market?
18mm Stent, 20mm Stent, 14mm Stent, Other Stents
What are the significant Applications of Radioactive Stent Used for Cancer Treatments Market?
Esophageal Cancer, Biliary Cancer, Others
All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.